100% Quality Guarantee
PhD-Level Technical Support
Key Features

AGX101 Biosimilar (TM4SF1) Antibody (HDBS0139)

SKU HDBS0139
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein TM4SF1
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

AGX101 Biosimilar (TM4SF1) Antibody (HDBS0139)

The AGX101 Biosimilar TM4SF1 Antibody is a cutting-edge research tool designed for studies involving TM4SF1, a transmembrane protein associated with cancer progression and metastasis. This monoclonal antibody, produced using advanced biotechnologies, specifically targets and binds to the TM4SF1 protein, allowing for precise detection and analysis in various experimental settings.TM4SF1, also known as a tumor-associated antigen, is overexpressed in numerous cancer types and is linked to increased tumor invasiveness and resistance to therapy. Understanding the role of TM4SF1 in cancer biology is crucial for developing targeted therapies and personalized treatment strategies for patients with aggressive tumors.

The AGX101 Biosimilar Anti-TM4SF1 Antibody is highly specific and sensitive, making it an invaluable asset for researchers investigating the molecular mechanisms underlying cancer progression and metastasis. Its compatibility with diverse research techniques, such as immunohistochemistry and flow cytometry, provides flexibility in experimental design and data interpretation. By utilizing this innovative antibody, scientists can further elucidate the complex functions of TM4SF1 and pave the way for novel therapeutic interventions in the fight against cancer.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose